AU3587599A - Single chain monoclonal antibody fusion reagents that regulate transcript ion in vivo - Google Patents

Single chain monoclonal antibody fusion reagents that regulate transcript ion in vivo

Info

Publication number
AU3587599A
AU3587599A AU35875/99A AU3587599A AU3587599A AU 3587599 A AU3587599 A AU 3587599A AU 35875/99 A AU35875/99 A AU 35875/99A AU 3587599 A AU3587599 A AU 3587599A AU 3587599 A AU3587599 A AU 3587599A
Authority
AU
Australia
Prior art keywords
vivo
monoclonal antibody
single chain
antibody fusion
chain monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35875/99A
Other languages
English (en)
Inventor
James P. Hoeffler
Marijane Russell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invitrogen Corp filed Critical Invitrogen Corp
Publication of AU3587599A publication Critical patent/AU3587599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU35875/99A 1997-11-28 1997-11-28 Single chain monoclonal antibody fusion reagents that regulate transcript ion in vivo Abandoned AU3587599A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/021407 WO1999028502A1 (fr) 1997-11-28 1997-11-28 Reactifs de fusion d'anticorps monoclonal a chaine unique regulant une transcription in vivo

Publications (1)

Publication Number Publication Date
AU3587599A true AU3587599A (en) 1999-06-16

Family

ID=22262117

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35875/99A Abandoned AU3587599A (en) 1997-11-28 1997-11-28 Single chain monoclonal antibody fusion reagents that regulate transcript ion in vivo

Country Status (3)

Country Link
EP (1) EP1040201A4 (fr)
AU (1) AU3587599A (fr)
WO (1) WO1999028502A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108060232A (zh) * 2017-12-13 2018-05-22 安徽师范大学 用于扩增乌龟雄激素受体（AR）基因的RT-qPCR引物和方法

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1242457T3 (da) 1999-12-28 2004-12-20 Esbatech Ag Intracellulære antistoffer [intracellulære antistoffer] med defineret struktur, der er stabil i et reducerende miljö, og anvendelse deraf
US6696620B2 (en) 2000-05-02 2004-02-24 Epicyte Pharmaceutical, Inc. Immunoglobulin binding protein arrays in eukaryotic cells
US6406863B1 (en) * 2000-06-23 2002-06-18 Genetastix Corporation High throughput generation and screening of fully human antibody repertoire in yeast
US6410246B1 (en) * 2000-06-23 2002-06-25 Genetastix Corporation Highly diverse library of yeast expression vectors
US6410271B1 (en) * 2000-06-23 2002-06-25 Genetastix Corporation Generation of highly diverse library of expression vectors via homologous recombination in yeast
US7005503B2 (en) 2002-02-08 2006-02-28 Genetastix Corporation Human monoclonal antibody against coreceptors for human immunodeficiency virus
US7138496B2 (en) 2002-02-08 2006-11-21 Genetastix Corporation Human monoclonal antibodies against human CXCR4
US6610472B1 (en) * 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast
US20030059834A1 (en) * 2001-02-01 2003-03-27 Chang Nancy T. Methods to generate and identify monoclonal antibodies to a large number of human antigens
ATE434040T1 (de) 2001-10-01 2009-07-15 Dyax Corp Mehrkettige eukaryontische display-vektoren und deren verwendungen
AU2003209059A1 (en) * 2002-02-08 2003-09-02 Genetastix Corporation Human monoclonal antibodies against membrane proteins
DK1506236T3 (da) 2002-05-22 2013-03-04 Esbatech A Novartis Co Llc Immunglobulin-frameworks, der udviser forbedret stabilitet i det intracellulære miljø og fremgangsmåder til identifikation deraf
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
US8691730B2 (en) 2007-09-14 2014-04-08 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
KR101323827B1 (ko) * 2010-01-08 2013-10-31 키스트 유럽 에프게엠베하 강직성척추염 진단용 프라이머 및 이를 이용한 강직성 척추염 진단 방법
EP2593594B1 (fr) 2010-07-16 2017-09-27 Adimab, LLC Banques d'anticorps

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525491A (en) * 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
US5395750A (en) * 1992-02-28 1995-03-07 Hoffmann-La Roche Inc. Methods for producing proteins which bind to predetermined antigens
WO1994021294A1 (fr) * 1993-03-19 1994-09-29 Bigner Darell D Procede de traitement de tumeurs a l'aide d'anticorps
US5610013A (en) * 1993-07-22 1997-03-11 Ludwig Institute For Cancer Research Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
US5658763A (en) * 1993-10-25 1997-08-19 Creative Biomolecules, Inc. Methods and compositions for high protein production from non-native DNA
US6004746A (en) * 1994-07-20 1999-12-21 The General Hospital Corporation Interaction trap systems for detecting protein interactions
FR2732348B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Systeme d'expression conditionnel
GB2344886B (en) * 1999-03-10 2000-11-01 Medical Res Council Selection of intracellular immunoglobulins
DK1242457T3 (da) * 1999-12-28 2004-12-20 Esbatech Ag Intracellulære antistoffer [intracellulære antistoffer] med defineret struktur, der er stabil i et reducerende miljö, og anvendelse deraf

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108060232A (zh) * 2017-12-13 2018-05-22 安徽师范大学 用于扩增乌龟雄激素受体（AR）基因的RT-qPCR引物和方法

Also Published As

Publication number Publication date
EP1040201A4 (fr) 2001-11-21
WO1999028502A1 (fr) 1999-06-10
EP1040201A1 (fr) 2000-10-04

Similar Documents

Publication Publication Date Title
AU3587599A (en) Single chain monoclonal antibody fusion reagents that regulate transcript ion in vivo
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
AU1462300A (en) Human pan-hcv human monoclonal antibodies
IL128406A0 (en) Monoclonal antibodies
AU5752696A (en) Dna binding antibodies
AU1704099A (en) Monoclonal human natural antibodies
AU1550300A (en) Antigen-binding proteins
AU4992997A (en) Humanized anti-cd11a antibodies
GB9809839D0 (en) Antibody
AU3827695A (en) Antigen-binding fusion proteins
EP1073464A4 (fr) Anticorps monoclonaux presentant une immunogenicite reduite
AU8432498A (en) Human-cd28 specific monoclonal antibodies for antigen non-specific activation oft-lymphocytes
AU5869596A (en) Anti-gp130 monoclonal antibodies
AU1687500A (en) Antihuman vegf monoclonal antibody
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
AU7072998A (en) Immunoassays using anti-allotypic monoclonal antibodies
AU4556699A (en) Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples
AU2645297A (en) Hepatitis b monoclonal antibodies
HUP0103152A2 (hu) G3BP fehérje elleni monoklonális antitestek és alkalmazásuk
AU5970198A (en) Anti-fas antibodies
AU2759899A (en) Purified sperm surface antigen, monoclonal antibody therefor and application therefor
GB9818915D0 (en) Antibodies
GB9828700D0 (en) Antibody
GB9718911D0 (en) Monoclonal antibodies
AU2793297A (en) Anti-human lect2 antibody, cells producing the same, and method and kit for assaying the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase